a comparison of success rate of blind endotracheal intubation through i-gel and ambu auragain in adult.

comparison of i-gelTM and ambu AuraGain as a conduit for blind endotracheal intubation in adult patients in elective surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059006

Enrollment

130

Registered

2023-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T758- Other specified effects of external causes Health Condition 2: T07- Unspecified multiple injuries

Interventions

Intervention1: AMBU AURAGAIN: The Ambu AuraGain laryngeal mask airway (Ambu A/S, Ballerup Denmark) is a newer second generation supraglottic airway device launched in June 2014. It is a single use SAD

Eligibility

Inclusion criteria

Inclusion criteria: BELONGING TO ASA PHYSICAL STATUS I OR II.

Exclusion criteria

Exclusion criteria: Patients with pregnancy, known or predicted difficult airway, reduced lung compliance, inter incisor gap >35 kg/m2 , High risk for pulmonary aspiration (non fasted, gastroesophageal reflux disease).

Design outcomes

Primary

Measure	Time frame
To compare success rate of blind endotracheal intubation through i-gelTM & Ambu AuraGain.Timepoint: 48weeks	—

Secondary

Measure	Time frame
1. To compare success rate of device [SAD] insertion [Number of insertion attempts, time of insertion]. 2. Postoperative complications. Blood on device. Sore throat. Hoarseness of voice. DysphagiaTimepoint: 2 YEARS	—

Countries

India

Contacts

Public Contactdr rajat sisodia

MAHARAJA AGRASEN NMEDICAL COLLEGE, AGROHA.

Sheetalbhatia1234@gmail.com9812426301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026